(partial Tender Result)ICB/FW/EPSA6/GF-HAPCO/NFMIII/ARV/OI/PH/03/22
July 19, 2022
Tender Code: ICB/FW/EPSA6/GF-HAPCO/NFMIII/ARV/OI/PH/03/22
Award Status: Partial Winners List
Award Date: 07/19/2022
Tender Award: Download
Unsuccessful Bidders:
Technical Evaluation Result:
|
|
Company Name: | Document No: OF/TM/ HO-14 | ||||||||||||
| የኢትዮጵያመድሃኒትአቅራቢኤጀንሲ | ||||||||||||||
| Ethiopian Pharmaceuticals Supply Agency | ||||||||||||||
| Title: | Effective date : 13/09/2019 | |||||||||||||
| Partial Official winner list | Rev. No.: 0 | |||||||||||||
| Partial Official winner list of tender No : ICB/FW/EPSA6/GF-HAPCO/NFMIII/ARV/OI/PH/03/22 | ||||||||||||||
| Item NO | Description | offered pack size/unit | Estimated total Quantity with winner pack size | No of bidders to be awarded | Winner | Currency | Unit FOB price | allocated volume | Payment Term | Port of shipment | Delivery Time | Remark | ||
| Supplier | Country | |||||||||||||
| 1 | Abacavir (ABC) – 300mg – Tablet | 60 | 396,800 | 2 | Pending | The result will be disclosed in near future | ||||||||
| 2 | Abacavir (ABC) + Lamivudine (3TC) – (120mg + 60mg) – Tablet | 60 | 455,450 | 2 | ||||||||||
| 3 | Amphotercin B- 50mg in vial –Injection (Liposomal) | Each | 36,015 | 2 | No qualified bidder | Retendered | ||||||||
| 4 | Atazanavir (ATV) + Ritonavir (RTV) – (300mg +100mg) – Tablet | 30 | 1,183,516 | 3 | Pending | The result will be disclosed in near future | ||||||||
| 5 | Darunavir (DRV) – 600mg – Tablet | 60 | 67,737 | 2 | ||||||||||
| 6 | Dolutegravir (DTG) – 50mg – Tablet | 30 | 459,047 | 2 | Shanghai Desano Bio-pharmaceutical Co.Ltd | China | USD | 1.27 | 275,428 | CAD | Shanghai | Within 60- 90 days from L/C opening date | Winner price | |
| Macleods Pharmaceuticals Ltd | India | USD | 1.6 | 183,619 | L/C | Mumbai | With in 60-90 days after L/C opening date | 2nd least price | ||||||
| 7 | Efavirenz (EFV) – 200mg – Capsule | 90 | 14,019 | 1 | Micro Labs Limited | India | USD | 3.43 | All | CAD | Mumbai | Within 60 – 90 days after L/C opening date | Winner price | |
| 8 | Efavirenz (EFV) – 50mg – Capsule | 30 | 26,498 | 1 | Cancelled | |||||||||
| 9 | Efavirenz (EFV) – 600mg – Tablet | 30 | 125,972 | 1 | Pending | The result will be disclosed in near future | ||||||||
| 10 | Lamivudine (3TC) – 150mg – Tablet | 60 | 396,335 | 2 | Micro Labs Limited | India | USD | 1.69 | 237,801 | CAD | Mumbai | Within 60 – 90 days after L/C opening date | Winner price | |
| Macleods Pharmaceuticals Ltd | India | USD | 1.93 | 158,534 | L/C | Mumbai | With in 60-90 days after L/C opening date | 2nd least price | ||||||
| 11 | Lamivudine (3TC) + Dolutegravir (DTG) + Tenofovir (TDF) – (300mg + 50mg + 300mg) – Tablet | 30 | 2,553,493 | 3 | Pending | The result will be disclosed in near future | ||||||||
| 12 | Lamivudine + Tenofovir – (300mg + 300mg) – Tablet | 30 | 971,468 | 3 | ||||||||||
| 13 | Lamivudine + Zidovudine – (150mg + 300mg) – Tablet | 60 | 906,337 | 3 | Shanghai Desano Bio-pharmaceutical Co.Ltd | China | USD | 4.40 | 543,802 | CAD | Shanghai | Within 60- 90 days from L/C opening date | winner price | |
| Micro Labs Limited | India | USD | 5.27 | 226,584 | CAD | Mumbai | Within 60 – 90 days after L/C opening date | 2nd least price | ||||||
| Hetro Labs Limited | India | USD | 5.32 | 135,951 | CAD | Mumbai | with in 60 – 90 days from L/C opening date | 3rd least price | ||||||
| 14 | Lamivudine + Zidovudine – (30mg + 60mg) – Tablet | 60 | 145565 | 1 | Pending | The result will be disclosed in near future | ||||||||
| 15 | Lopinavir + Ritonavir – (100mg + 25mg) – Tablet | 120 | 7146 | 2 | ||||||||||
| 16 | Lopinavir + Ritonavir – (200mg + 50mg) – Tablet | 120 | 212623 | 2 | ||||||||||
| 17 | Lopinavir + Ritonavir – (40mg + 10mg) – Capsule | 120 | 25,661 | 1 | Retendered | No qualified bidder | ||||||||
| 18 | Nevirapine – 10mg/1ml – Oral Suspension | 100 ml | 96,537 | 1 | Cipla Limited | India | USD | 1.25 | All | L/C | Mumbai | Within 60- 90 days from L/C opening date | ||
| 19 | Ritonavir (RTV) – 100mg – Tablet | 30 | 101,356 | 2 | Pending | The result will be disclosed in near future | ||||||||
| 20 | Sulphamethoxazole + Trimethoprim – (200mg + 40mg)/5ml – Suspension | 100 ml | 541,647 | 2 | Pending | |||||||||
| 21 | Sulphamethoxazole + Trimethoprim – (400mg + 80mg) – Tablet | 100×10 | 5,112 | 1 | Milan Laboratories | India | USD | 11.7 | 5,112 | L/C | JNPT port,/ Mumbai | Within 90 days after L/C opening date | ||
| 22 | Sulphamethoxazole + Trimethoprim – (800 mg + 160 mg) – Tablet | 100×10 | 138,096 | 2 | Pending | |||||||||
| 23 | Zidovudine – 10mg/ml – Oral Solution | 100 ml | 94,312 | Retendered | No qualified bidder | |||||||||
| 24 | Fluconazole – 100mg – Tablet | 100 ml | 36,015 | Retendered | No bidder | |||||||||
| 25 | Flucytosine – 500mg – Capsule | 10×10 | 3,797 | |||||||||||
| እባክዎ በዚህ ሰነድ ከመጠቀምዎ በፊት ትክክለኛ መሆኑን ያረጋግጡ | OF for Partial Official winner list OF/TM/HO-14 0, 13/09/2019 | |||||||||||||
| Make sure that this is the correct issue before use | ||||||||||||||
Partial Reasons for Rejection
| Tender no: ICB/FW/EPSA6/GF-HAPCO/NFMIII/ARV/OI/PH/03/22 | |||||
| Item No | Product Description | Name of competitor suppliers | Status | Reason of unsuccessfulness | Remark |
| 1 | Abacavir (ABC) – 300mg – Tablet | Pending | |||
| 2 | Abacavir (ABC) + Lamivudine (3TC) – (120mg + 60mg) – Tablet | ||||
| 3 | Amphotercin B- 50mg in vial –Injection (Liposomal) | Bharat Serums and Vaccines Limited | Unsuccessful | Offered longer delivery date | |
| Emcure Pharmaceuticals LTD | Unsuccessful | EFDA product registration ,SRA certificate and EFDA GMP certificate were not submitted | |||
| 4 | Atazanavir (ATV) + Ritonavir (RTV) – (300mg +100mg) – Tablet | Pending | |||
| 5 | Darunavir (DRV) – 600mg – Tablet | ||||
| 6 | Dolutegravir (DTG) – 50mg – Tablet | Emcure Pharmaceuticals LTD | Unsuccessful | Price incompetence | |
| Aurobindo Pharma Limited | Unsuccessful | Price incompetence | |||
| Cipla Limited | Unsuccessful | Price incompetence | |||
| Hetro Labs Limited | Unsuccessful | Price incompetence | |||
| Laurus Labs Limited | Unsuccessful | Price incompetence | |||
| Micro Labs Limited | Unsuccessful | Price incompetence | |||
| 9 | Efavirenz (EFV) – 600mg – Tablet | Pending | |||
| 10 | Lamivudine (3TC) – 150mg – Tablet | Victory Global Pharma FZC | Unsuccessful | Price incompetence | |
| 11 | Lamivudine (3TC) + Dolutegravir (DTG) + Tenofovir (TDF) – (300mg + 50mg + 300mg) – Tablet | Pending | |||
| 12 | Lamivudine + Tenofovir – (300mg + 300mg) – Tablet | ||||
| 13 | Lamivudine + Zidovudine – (150mg + 300mg) – Tablet | Cipla Limited | Unsuccessful | Price incompetence | |
| Macleods Pharmaceuticals Ltd | Unsuccessful | Price incompetence | |||
| Victory Global Pharma FZC | Unsuccessful | Price incompetence | |||
| 14 | Lamivudine + Zidovudine – (30mg + 60mg) – Tablet | Pending | |||
| 15 | Lopinavir + Ritonavir – (100mg + 25mg) – Tablet | ||||
| 16 | Lopinavir + Ritonavir – (200mg + 50mg) – Tablet | ||||
| 17 | Lopinavir + Ritonavir – (40mg + 10mg) – Capsule | No qualified bidder | |||
| 18 | Nevirapine – 10mg/1ml – Oral Suspension | Aurobindo Pharma Limited | Unsuccessful | Due to distance of port of shipment | |
| 19 | Nevirapine – 10mg/1ml – Oral Suspension | Pending | |||
| 20 | Sulphamethoxazole + Trimethoprim – (200mg + 40mg)/5ml – Suspension | Pending | |||
| 21 | Sulphamethoxazole + Trimethoprim – (400mg + 80mg) – Tablet | Leben Laboratories Pvt.Ltd | Unsuccessful | Price incompetence | |
| Micro Labs Limited | Unsuccessful | EFDA registration certificate ,SRA and GMP certificate were not submitted | |||
| 22 | Sulphamethoxazole + Trimethoprim – (800 mg + 160 mg) – Tablet | Pending | |||
| 23 | Zidovudine – 10mg/ml – Oral Solution | Hetro Labs Limited | Unsuccessful | The unit was out of EPSA specification | |
| Macleods Pharmaceuticals Ltd | Unsuccessful | Offered short shelf life | |||
| 24 | Fluconazole – 100mg – Tablet | No bidder | |||
| 25 | Flucytosine – 500mg – Capsule | No bidder | |||
| እባክዎ በዚህ ሰነድ ከመጠቀምዎ በፊት ትክክለኛ መሆኑን ያረጋግጡ | OF for Partial Reasons for Rejection OF/TM/HO-15, 0, 13/09/2019 | ||||
| Make sure that this is the correct issue before use | |||||